1,2-dimethylhydrazine multiple interactions ISO RGD:1318104 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TNPO1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1318104 6480464 1, 2-Dimethylhydrazine results in decreased expression of TNPO1 mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO RGD:1318103 6480464 1-nitropyrene results in increased expression of TNPO1 mRNA CTD PMID:19041380 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of TNPO1 mRNA CTD PMID:29097150 17beta-estradiol increases expression ISO RGD:1318103 6480464 Estradiol results in increased expression of TNPO1 mRNA CTD PMID:16514628 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1318103 6480464 2 more ... CTD PMID:31675489 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1318104 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1318104 6480464 Tetrachlorodibenzodioxin results in increased expression of TNPO1 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TNPO1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318103 6480464 Tetrachlorodibenzodioxin affects the expression of TNPO1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318104 6480464 Tetrachlorodibenzodioxin affects the expression of TNPO1 mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of TNPO1 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1318103 6480464 beta-methylcholine affects the expression of TNPO1 mRNA CTD PMID:21179406 acrolein multiple interactions ISO RGD:1318103 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TNPO1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TNPO1 mRNA CTD PMID:32699268 afimoxifene decreases expression ISO RGD:1318103 6480464 afimoxifene results in decreased expression of TNPO1 mRNA CTD PMID:16514628 aflatoxin B1 increases expression ISO RGD:1318104 6480464 Aflatoxin B1 results in increased expression of TNPO1 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1318103 6480464 Aflatoxin B1 results in decreased methylation of TNPO1 gene, Aflatoxin B1 results in decreased methylation of TNPO1 intron CTD PMID:27153756 , PMID:30157460 Aflatoxin B2 alpha decreases methylation ISO RGD:1318103 6480464 aflatoxin B2 results in decreased methylation of TNPO1 intron CTD PMID:30157460 all-trans-retinoic acid affects expression ISO RGD:1318103 6480464 Tretinoin affects the expression of TNPO1 mRNA CTD PMID:15498508 all-trans-retinoic acid decreases expression ISO RGD:1318103 6480464 Tretinoin results in decreased expression of TNPO1 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:1318103 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TNPO1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TNPO1 mRNA CTD PMID:32699268 aristolochic acid A decreases expression ISO RGD:1318103 6480464 aristolochic acid I results in decreased expression of TNPO1 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1318103 6480464 arsenite inhibits the reaction [G3BP1 protein binds to TNPO1 mRNA] CTD PMID:32406909 benzo[a]pyrene increases methylation ISO RGD:1318103 6480464 Benzo(a)pyrene results in increased methylation of TNPO1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1318103 6480464 Benzo(a)pyrene affects the methylation of TNPO1 intron CTD PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1318103 6480464 7 more ... CTD PMID:19150397 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TNPO1 mRNA CTD PMID:33296240 bisphenol A increases expression ISO RGD:1318104 6480464 bisphenol A results in increased expression of TNPO1 mRNA CTD PMID:33221593 butanal decreases expression ISO RGD:1318103 6480464 butyraldehyde results in decreased expression of TNPO1 mRNA CTD PMID:26079696 cadmium atom affects expression ISO RGD:1318103 6480464 Cadmium affects the expression of TNPO1 mRNA CTD PMID:23369406 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of TNPO1 mRNA CTD PMID:33453195 cadmium sulfate increases expression ISO RGD:1318103 6480464 cadmium sulfate results in increased expression of TNPO1 mRNA CTD PMID:12064557 , PMID:14676411 calcitriol decreases expression ISO RGD:1318103 6480464 Calcitriol results in decreased expression of TNPO1 mRNA CTD PMID:16847355 calcitriol decreases activity ISO RGD:1318103 6480464 Calcitriol results in decreased activity of TNPO1 protein CTD PMID:10843682 calcitriol multiple interactions ISO RGD:1318103 6480464 [Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein]] which results in increased activity of MAP3K5 protein, Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein] CTD PMID:10843682 carbon nanotube increases expression ISO RGD:1318104 6480464 Nanotubes more ... CTD PMID:25554681 casticin decreases expression ISO RGD:1318104 6480464 casticin results in decreased expression of TNPO1 mRNA CTD PMID:28444820 cobalt dichloride increases expression ISO RGD:1318103 6480464 cobaltous chloride results in increased expression of TNPO1 mRNA CTD PMID:19376846 copper(II) sulfate increases expression ISO RGD:1318103 6480464 Copper Sulfate results in increased expression of TNPO1 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1318103 6480464 Cyclosporine results in increased expression of TNPO1 mRNA CTD PMID:20106945 , PMID:25562108 dicrotophos decreases expression ISO RGD:1318103 6480464 dicrotophos results in decreased expression of TNPO1 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1318103 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 elemental selenium decreases expression ISO RGD:1318103 6480464 Selenium results in decreased expression of TNPO1 mRNA CTD PMID:19244175 entinostat decreases expression ISO RGD:1318103 6480464 entinostat results in decreased expression of TNPO1 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:1318103 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TNPO1 protein CTD PMID:23301498 flutamide increases expression EXP 6480464 Flutamide results in increased expression of TNPO1 mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:1318104 6480464 Folic Acid results in decreased expression of TNPO1 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1318104 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TNPO1 mRNA CTD PMID:22206623 fulvestrant decreases expression ISO RGD:1318103 6480464 fulvestrant results in decreased expression of TNPO1 mRNA CTD PMID:16514628 hydrogen peroxide affects expression ISO RGD:1318103 6480464 Hydrogen Peroxide affects the expression of TNPO1 mRNA CTD PMID:20044591 ionomycin increases expression ISO RGD:1318104 6480464 Ionomycin results in increased expression of TNPO1 mRNA CTD PMID:10843682 isoprenaline increases expression ISO RGD:1318104 6480464 Isoproterenol results in increased expression of TNPO1 mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:1318103 6480464 Ivermectin results in decreased expression of TNPO1 protein CTD PMID:32959892 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of TNPO1 mRNA CTD PMID:20080153 lipopolysaccharide multiple interactions ISO RGD:1318103 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of TNPO1 mRNA CTD PMID:26667767 manumycin A multiple interactions ISO RGD:1318103 6480464 Acetylcysteine inhibits the reaction [manumycin results in decreased expression of TNPO1] CTD PMID:19409983 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of TNPO1 mRNA CTD PMID:19564919 Methylazoxymethanol acetate decreases expression EXP 6480464 Methylazoxymethanol Acetate results in decreased expression of TNPO1 mRNA CTD PMID:28349193 methylmercury chloride increases expression ISO RGD:1318103 6480464 methylmercuric chloride results in increased expression of TNPO1 mRNA CTD PMID:23179753 methylmercury chloride decreases expression ISO RGD:1318103 6480464 methylmercuric chloride results in decreased expression of TNPO1 mRNA CTD PMID:28001369 microcystin-LR decreases expression ISO RGD:1318104 6480464 cyanoginosin LR results in decreased expression of TNPO1 protein CTD PMID:26984711 N-acetyl-L-cysteine multiple interactions ISO RGD:1318103 6480464 Acetylcysteine inhibits the reaction [manumycin results in decreased expression of TNPO1] CTD PMID:19409983 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TNPO1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1318103 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TNPO1 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1318104 6480464 Acetaminophen affects the expression of TNPO1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1318103 6480464 Acetaminophen results in increased expression of TNPO1 mRNA CTD PMID:26497421 , PMID:29067470 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 pentachlorophenol decreases expression ISO RGD:1318104 6480464 Pentachlorophenol results in decreased expression of TNPO1 mRNA CTD PMID:23892564 phenylmercury acetate increases expression ISO RGD:1318103 6480464 Phenylmercuric Acetate results in increased expression of TNPO1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1318103 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNPO1 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:1318104 6480464 pirinixic acid results in decreased expression of TNPO1 mRNA CTD PMID:18445702 raloxifene decreases expression ISO RGD:1318103 6480464 Raloxifene Hydrochloride results in decreased expression of TNPO1 mRNA CTD PMID:16514628 resveratrol multiple interactions ISO RGD:1318103 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of TNPO1 mRNA CTD PMID:26667767 resveratrol increases expression ISO RGD:1318104 6480464 resveratrol results in increased expression of TNPO1 protein CTD PMID:25505154 SB 431542 multiple interactions ISO RGD:1318103 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom decreases expression ISO RGD:1318103 6480464 Selenium results in decreased expression of TNPO1 mRNA CTD PMID:19244175 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of TNPO1 protein CTD PMID:29459688 Soman increases expression EXP 6480464 Soman results in increased expression of TNPO1 mRNA CTD PMID:19281266 sunitinib increases expression ISO RGD:1318103 6480464 Sunitinib results in increased expression of TNPO1 mRNA CTD PMID:31533062 tamibarotene decreases expression ISO RGD:1318103 6480464 tamibarotene results in decreased expression of TNPO1 mRNA CTD PMID:15498508 tert-butyl hydroperoxide increases expression ISO RGD:1318103 6480464 tert-Butylhydroperoxide results in increased expression of TNPO1 mRNA CTD PMID:15336504 testosterone enanthate affects expression ISO RGD:1318103 6480464 testosterone enanthate affects the expression of TNPO1 mRNA CTD PMID:17440010 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TNPO1 mRNA CTD PMID:23411599 , PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TNPO1 mRNA CTD PMID:25729387 trimellitic anhydride increases expression ISO RGD:1318104 6480464 trimellitic anhydride results in increased expression of TNPO1 mRNA CTD PMID:19042947 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of TNPO1 mRNA CTD PMID:30589522 Triptolide increases expression ISO RGD:1318104 6480464 triptolide results in increased expression of TNPO1 mRNA CTD PMID:32835833 troglitazone decreases expression ISO RGD:1318104 6480464 troglitazone results in decreased expression of TNPO1 mRNA CTD PMID:28973697 uranium atom affects expression ISO RGD:1318103 6480464 Uranium affects the expression of TNPO1 mRNA CTD PMID:15672453 urethane increases expression ISO RGD:1318103 6480464 Urethane results in increased expression of TNPO1 mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of TNPO1 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1318103 6480464 Valproic Acid affects the expression of TNPO1 mRNA CTD PMID:26272509 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of TNPO1 mRNA CTD PMID:29427782 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of TNPO1 mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:1318103 6480464 Valproic Acid results in decreased expression of TNPO1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid multiple interactions ISO RGD:1318103 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of TNPO1 mRNA CTD PMID:27188386 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of TNPO1 mRNA CTD PMID:23034163 vitamin E decreases expression ISO RGD:1318103 6480464 Vitamin E results in decreased expression of TNPO1 mRNA CTD PMID:19244175